BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9333347)

  • 1. Sequential analysis of censored survival data from three treatment groups.
    Betensky RA
    Biometrics; 1997 Sep; 53(3):807-22. PubMed ID: 9333347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage procedure for survival studies with surrogate endpoints.
    Flandre P; O'Quigley J
    Biometrics; 1995 Sep; 51(3):969-76. PubMed ID: 7548712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiple-step selection procedure with sequential protection of preferred treatments.
    Chen TT; Simon R
    Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric regression estimates with censored data: local linear smoothers and their applications.
    Kim HT; Truong YK
    Biometrics; 1998 Dec; 54(4):1434-44. PubMed ID: 9883543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chop-lump tests for vaccine trials.
    Follmann D; Fay MP; Proschan M
    Biometrics; 2009 Sep; 65(3):885-93. PubMed ID: 19210727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An implicitly defined parametric model for censored survival data and covariates.
    Piantadosi S; Crowley J
    Biometrics; 1995 Mar; 51(1):249-58. PubMed ID: 7766780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the design and analysis of randomized clinical trials with multiple endpoints.
    Tang DI; Geller NL; Pocock SJ
    Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups.
    Kawaguchi A; Koch GG; Ramaswamy R
    Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantel-Haenszel test statistics for correlated binary data.
    Zhang J; Boos DD
    Biometrics; 1997 Dec; 53(4):1185-98. PubMed ID: 9423245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
    Pujol JL; Carestia L; Daurès JP
    Br J Cancer; 2000 Jul; 83(1):8-15. PubMed ID: 10883661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy evaluation for monotherapies in two-by-two factorial trials.
    Hung HM; Chi GY; O'Neill RT
    Biometrics; 1995 Dec; 51(4):1483-93. PubMed ID: 8589235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.